ArticleFrontiers in molecular biosciences2022

Nicotinamide as potential biomarker for Alzheimer's disease: A translational study based on metabolomics.

María C Dalmasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.